{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:00:13Z","timestamp":1771592413523,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1124\/dmd.121.000554","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T17:15:17Z","timestamp":1631207717000},"page":"1100-1108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Complex Cytochrome P450 Kinetics Due to Multisubstrate Binding and Sequential Metabolism. Part 2. Modeling of Experimental Data"],"prefix":"10.1016","volume":"49","author":[{"given":"Erickson M.","family":"Paragas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Korzekwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.121.000554_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"10.1124\/dmd.121.000554_bib2","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/acs.molpharmaceut.6b00436","article-title":"Mechanism-based inhibition of CYP3A4 by podophyllotoxin: aging of an intermediate is important for in vitro\/in vivo correlations","volume":"13","author":"Barnaba","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.121.000554_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2165\/00003088-199018060-00002","article-title":"Formation of active metabolites of psychotropic drugs. An updated review of their significance","volume":"18","author":"Caccia","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.121.000554_bib4","doi-asserted-by":"crossref","first-page":"14143","DOI":"10.1021\/bi051689t","article-title":"Cooperative binding of midazolam with testosterone and alpha-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study","volume":"44","author":"Cameron","year":"2005","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.121.000554_bib5","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1021\/acs.biochem.1c00161","article-title":"Midazolam as a probe for drug-drug interactions mediated by CYP3A4: homotropic allosteric mechanism of site-specific hydroxylation","volume":"60","author":"Denisov","year":"2021","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.121.000554_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/17460441.2017.1367280","article-title":"Reaction phenotyping to assess victim drug-drug interaction risks","volume":"12","author":"Di","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/dmd.121.000554_bib7","doi-asserted-by":"crossref","first-page":"13682","DOI":"10.1073\/pnas.0603236103","article-title":"Structural basis for ligand promiscuity in cytochrome P450 3A4","volume":"103","author":"Ekroos","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.121.000554_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0091270009343005","article-title":"Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans","volume":"50","author":"Farid","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.121.000554_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2165\/00003088-198510030-00002","article-title":"Active drug metabolites. An overview of their relevance in clinical pharmacokinetics","volume":"10","author":"Garattini","year":"1985","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.121.000554_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0003-9861(02)00484-8","article-title":"Analysis of homotropic and heterotropic cooperativity of diazepam oxidation by CYP3A4 using site-directed mutagenesis and kinetic modeling","volume":"409","author":"He","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.121.000554_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00228-002-0439-4","article-title":"Protein binding of ketamine and its active metabolites to human serum","volume":"58","author":"Hijazi","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.121.000554_bib13","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1124\/dmd.108.021733","article-title":"Multiple substrate binding by cytochrome P450 3A4: estimation of the number of bound substrate molecules","volume":"36","author":"Kapelyukh","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000554_bib14","first-page":"4187","article-title":"Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11","volume":"51","author":"Kawato","year":"1991","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.121.000554_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-62703-758-7_8","article-title":"Enzyme kinetics of oxidative metabolism: cytochromes P450","volume":"1113","author":"Korzekwa","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.121.000554_bib16","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1021\/bi9715627","article-title":"Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites","volume":"37","author":"Korzekwa","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.121.000554_bib12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2174\/1568026043387205","article-title":"Crystallization of cytochromes P450 and substrate-enzyme interactions","volume":"4","author":"Li","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/dmd.121.000554_bib17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1124\/dmd.115.068601","article-title":"Mechanistic modeling to predict midazolam metabolite exposure from in vitro data","volume":"44","author":"Nguyen","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000554_bib18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2174\/156802611794480873","article-title":"Predicting clearance in humans from in vitro data","volume":"11","author":"Obach","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/dmd.121.000554_bib19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/pr.111.005439","article-title":"Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy","volume":"65","author":"Obach","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.121.000554_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.talanta.2007.11.060","article-title":"An improved HPLC method for rapid quantitation of diazepam and its major metabolites in human plasma","volume":"75","author":"Rouini","year":"2008","journal-title":"Talanta"},{"key":"10.1124\/dmd.121.000554_bib21","doi-asserted-by":"crossref","unstructured":"Schoch GA, Yano JK, Sansen S, Dansette PM, Stout CD, Johnson EF (2008) Determinants of cytochrome P450 2C8 substrate binding: Structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid 283:17227-17237.","DOI":"10.1074\/jbc.M802180200"},{"key":"10.1124\/dmd.121.000554_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1073\/pnas.1616198114","article-title":"Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4","volume":"114","author":"Sevrioukova","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.121.000554_bib23","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1021\/bi300894z","article-title":"Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules","volume":"51","author":"Shah","year":"2012","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.121.000554_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/clpt.2013.187","article-title":"Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drug","volume":"95","author":"Vieira","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.121.000554_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-62703-758-7_6","article-title":"Multienzyme kinetics and sequential metabolism","volume":"1113","author":"Wienkers","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.121.000554_bib26","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1021\/acs.molpharmaceut.8b00129","article-title":"Improved predictions of drug-drug interactions mediated by time-dependent inhibition of CYP3A","volume":"15","author":"Yadav","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.121.000554_bib27","doi-asserted-by":"crossref","first-page":"107449","DOI":"10.1016\/j.pharmthera.2019.107449","article-title":"Time-dependent enzyme inactivation: numerical analyses of in vitro data and prediction of drug-drug interactions","volume":"206","author":"Yadav","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.121.000554_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjp.0705808","article-title":"Identification of the active metabolite of ticlopidine from rat in vitro metabolites","volume":"142","author":"Yoneda","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.121.000554_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1389200054021834","article-title":"Enzyme kinetics for clinically relevant CYP inhibition","volume":"6","author":"Zhang","year":"2005","journal-title":"Curr Drug Metab"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624080760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624080760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.121.000554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:53:22Z","timestamp":1740056002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624080760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0090955624080760"],"URL":"https:\/\/doi.org\/10.1124\/dmd.121.000554","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complex Cytochrome P450 Kinetics Due to Multisubstrate Binding and Sequential Metabolism. Part 2. Modeling of Experimental Data","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.121.000554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}